Clemens Grassberger, PhD - Related publications

Affiliations: 
2014 Medical Physics ETH Universität Zürich/Harvard University 
 2014- Radiation Oncology Harvard University, Cambridge, MA, United States 
Area:
Radiation Physics; Biophysics; Immunomodulation
Website:
https://gray.mgh.harvard.edu/people-directory/research/66-clemens-grassberger-phd
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
17 most relevant papers in past 60 days:
Year Citation  Score
2022 Kiyohara E, Tanemura A, Sakura K, Nakajima T, Myoui A, Yamazaki N, Kiyohara Y, Katayama I, Fujimoto M, Kaneda Y. A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma. Cancer Immunology, Immunotherapy : Cii. PMID 34984539 DOI: 10.1007/s00262-021-03122-z   
2022 Martin C, Cuello M, Barajas O, Recondo G, Aruachan S, Perroud H, Sena S, Bonilla C, Orlandi F, Berutti S, Garcia Cocco V, Gomez A, Korbenfeld E, Zapata M, Cundom J, et al. Real-world evaluation of molecular testing and treatment patterns for EGFR mutations in non-small cell lung cancer in Latin America. Molecular and Clinical Oncology. 16: 6. PMID 34881026 DOI: 10.3892/mco.2021.2439   
2022 Lee H, Kim BR, Kim KH, Lee DH, Na JI. One-Year Effectiveness and Safety of Dupilumab Treatment for Moderate-to-Severe Atopic Dermatitis in Korean Patients: A Real-World Retrospective Analysis. Allergy, Asthma & Immunology Research. 14: 117-122. PMID 34983111 DOI: 10.4168/aair.2022.14.1.117   
2022 Van Den Heede K, Chidambaram S, Van Slycke S, Brusselaers N, Warfvinge CF, Ohlsson H, Gustafsson R, Nordenström E, Almquist M. Long-term survival of metastatic small intestine neuroendocrine tumors: a meta-analysis. Endocrine-Related Cancer. PMID 34982042 DOI: 10.1530/ERC-21-0354   
2022 Zeidan AM, DeAngelo DJ, Palmer J, Seet CS, Tallman MS, Wei X, Raymon H, Sriraman P, Kopytek S, Bewersdorf JP, Burgess MR, Hege K, Stock W. Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes. Annals of Hematology. PMID 34981142 DOI: 10.1007/s00277-021-04734-2   
2022 Park JY, Jang SH, Lee CY, Kim T, Chung SJ, Lee YJ, Kim HI, Kim JH, Park S, Hwang YI, Jung KS. Pretreatment neutrophil-to-lymphocyte ratio and cigarette smoking as prognostic factors in patients with advanced NSCLC treated with osimertinib. Tuberculosis and Respiratory Diseases. PMID 35045686 DOI: 10.4046/trd.2021.0139   
2022 Levy A, Mercier O, Le Péchoux C. Indications and Parameters Around Postoperative Radiation Therapy for Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101774. PMID 34985927 DOI: 10.1200/JCO.21.01774   
2022 Kim CG, Hwang SH, Kim KH, Yoon HI, Shim HS, Lee JH, Han Y, Ahn BC, Hong MH, Kim HR, Cho BC, Cho A, Lim SM. Predicting treatment outcomes using F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy. Therapeutic Advances in Medical Oncology. 14: 17588359211068732. PMID 35035536 DOI: 10.1177/17588359211068732   
2022 Xu Z, Xu M, Li M, Cui Z, Bai H, Shang H, Zhao J, Wu L, Zhang F. Effects of I125 seed stent implantation combined with arterial infusion chemoembolization on tumor markers, p53 expression, and prognosis in patients with cholangiocarcinoma. Bioengineered. 13: 2943-2950. PMID 35038960 DOI: 10.1080/21655979.2021.2022263   
2022 Zhou B, Gong Q, Li B, Qie HL, Li W, Jiang HT, Li HF. Clinical outcomes and safety of osimertinib plus anlotinib for patients with previously treated EGFR T790M-positive NSCLC: A retrospective study. Journal of Clinical Pharmacy and Therapeutics. PMID 35023208 DOI: 10.1111/jcpt.13591   
2022 Li C, Lu Z, He M, Sui J, Lin T, Xie K, Sun J, Ni X. Augmented reality-guided positioning system for radiotherapy patients. Journal of Applied Clinical Medical Physics. PMID 34985188 DOI: 10.1002/acm2.13516   
2022 Frezoulis P, Harper A. The role of toceranib phosphate in dogs with non-mast cell neoplasia: A systematic review. Veterinary and Comparative Oncology. PMID 34981886 DOI: 10.1111/vco.12799   
2022 Liu D, Yang T, Ma W, Wang Y. Clinical strategies to manage adult glioblastoma patients without MGMT hypermethylation. Journal of Cancer. 13: 354-363. PMID 34976195 DOI: 10.7150/jca.63595   
2022 Shih SR, Chen KH, Lin KY, Yang PC, Chen KY, Wang CW, Chen CN, Lin CF, Lin CC. Immunotherapy in anaplastic thyroid cancer: Case series. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 35031200 DOI: 10.1016/j.jfma.2022.01.003   
2022 Kempf E, Priou S, Lamé G, Daniel C, Bellamine A, Sommacale D, Belkacemi Y, Bey R, Galula G, Taright N, Tannier X, Rance B, Flicoteaux R, Hemery F, Audureau E, ... , et al. Impact of two waves of Sars-Cov2 outbreak on the number, clinical presentation, care trajectories and survival of patients newly referred for a colorectal cancer: A French multicentric cohort study from a large group of University hospitals. International Journal of Cancer. PMID 35001364 DOI: 10.1002/ijc.33928   
2022 Bai H, Yuan F, Liang B, Sun H, Gao Y, Jin M, Xing X. Clinicopathological characteristics and treatment of patients with high-grade endometrial stromal sarcoma: A retrospective study of 40 cases. Medicine. 101: e28490. PMID 35029198 DOI: 10.1097/MD.0000000000028490   
2022 Wang CL, Gao LT, Lyu CX, Zhang Q, Zeng WQ, Fang WT, Zhu L, Fu XL. Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors. Medical Oncology (Northwood, London, England). 39: 25. PMID 34982283 DOI: 10.1007/s12032-021-01620-9